An Efficacy and Safety Study of Akkermansia Muciniphila AKM Lab-01 in Hypercholesterolaemia

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 10, 2025

Primary Completion Date

July 30, 2026

Study Completion Date

December 30, 2026

Conditions

Hypercholesterolaemia

Interventions

DIETARY_SUPPLEMENT

Probiotic

Subjects receive AKM Lab-01 Enteric-coated once daily by oral, 34B TFU/day , within half an hour after breakfast for 3 months.

DIETARY_SUPPLEMENT

Placebo

Subjects receive placebo once daily by oral, one capsule/day, within half an hour after breakfast for 3 months.

All Listed Sponsors

lead

Moon (Guangzhou) Biotechnology Co., Ltd.

INDUSTRY

NCT06974266 - An Efficacy and Safety Study of Akkermansia Muciniphila AKM Lab-01 in Hypercholesterolaemia | Biotech Hunter | Biotech Hunter